Eli Lilly and Company (LLY) Gains Approval in Australia for Early
Alzheimer’s Treatment
-
Eli Lilly and Company (NYSE:LLY) recently announced that Australia’s
Therapeutic Goods Administration (TGA) has approved Kisunla (donanemab) for
marketing....
۱ ساعت قبل
هیچ نظری موجود نیست:
ارسال یک نظر